Katarzyna Major, Aleksandra Bodys-Pełka, Marcin Grabowski, Małgorzata Lelonek
{"title":"心力衰竭患者的生活质量：新数据、新药物和设备。","authors":"Katarzyna Major, Aleksandra Bodys-Pełka, Marcin Grabowski, Małgorzata Lelonek","doi":"10.5603/cj.92243","DOIUrl":null,"url":null,"abstract":"<p><p>Quality of life (QoL) is a therapeutic goal in heart failure. There are many EBM therapies for improving QoL. In this study, data is presented on new pharmacotherapies and devices that impact QoL in the heart failure population.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919569/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quality of life in heart failure: New data, new drugs and devices.\",\"authors\":\"Katarzyna Major, Aleksandra Bodys-Pełka, Marcin Grabowski, Małgorzata Lelonek\",\"doi\":\"10.5603/cj.92243\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Quality of life (QoL) is a therapeutic goal in heart failure. There are many EBM therapies for improving QoL. In this study, data is presented on new pharmacotherapies and devices that impact QoL in the heart failure population.</p>\",\"PeriodicalId\":93923,\"journal\":{\"name\":\"Cardiology journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919569/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/cj.92243\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/cj.92243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Quality of life in heart failure: New data, new drugs and devices.
Quality of life (QoL) is a therapeutic goal in heart failure. There are many EBM therapies for improving QoL. In this study, data is presented on new pharmacotherapies and devices that impact QoL in the heart failure population.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
